Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025
1. Connect Biopharma presents at the ERS Congress 2025 in Amsterdam. 2. Two posters focus on rademikibart for asthma treatment. 3. Rademikibart targets IL-4Rα, blocking Th2 inflammatory pathway. 4. Significant unmet need for asthma and COPD treatments addressed. 5. Partnership with Simcere for development in China announced.